Royalty Pharma (RPRX) announced two major steps to enhance shareholder value. First, the Board of Directors has agreed to acquire its external manager, RP Management. This transaction to simplify ...

In a report released on January 17, Sean Lee from Citi reiterated a Buy rating on Innate Pharma (IPHA – Research Report), with a price target of $11.50. The company’s shares closed last Friday ...

Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...

1 These properties are especially valuable in the pharmaceutical industry, as nanomembranes provide efficient and sustainable solutions for separation and purification. Traditional separation methods, ...

LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...

Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

Walmart is refreshing its logo for the first time in nearly two decades, highlighting its evolution while also serving as a nod to its past, the big-box retailer announced Monday. The word mark on ...

The MACC uncovered the syndicate after RM700mil in loans were approved for civil servants involving a financial consulting company and bank officers in several financial institutions.

KUALA LUMPUR: The Malaysian Anti-Corruption Commission (MACC) and the Federal Bureau of Investigation (FBI) will increase cooperation to address the challenges in combatting corruption crimes at ...

MACC will focus on eradicating corruption in procurement, enforcement and grand corruption to help the country's economy, reduce leakages and return misappropriated national assets and money next ...

Sanofi S.A. Part Cert 0.06% €8.19M ...